Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization

Authors:

Abstract
Significance: An in vivo chemical screen in zebrafish identified glucocorticoids (GCs) as activators of hypoxia-inducible factor transcriptional responses in the liver. This cross-talk is conserved in human liver and requires glucocorticoid receptor signaling but not DNA binding. In human liver cells, GCs down-regulate Von Hippel Lindau expression at a posttranscriptional level most likely through c-src–mediated proteasomal degradation. Since the liver is an important regulator of blood glucose and hypoxia-inducible factors regulate gluconeogenesis/glycogen synthesis, cross-talk between these transcriptional regulators may be essential to control glucose metabolism in the liver. This identified, conserved, noncanonical pathway may have wider physiological significance in health and disease.
Funding Information
  • EC | FP7 | FP7 Health (HEALTH-F4-2010-242048)
  • RCUK | Medical Research Council (G1100247)
  • RCUK | Biotechnology and Biological Sciences Research Council (BB/M02332X/1)
  • EC | FP7 | FP7 Health (597F3-2012-305578)
  • EC | Horizon 2020 Framework Programme (Hep-CAR No 667273)
  • Associazione Italiana per la Ricerca sul Cancro (IG 10274)
  • Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute (GR-2011-02346749)

This publication has 54 references indexed in Scilit: